Acute coronary syndromes without ST-segment elevation - What is the role of early intervention?

New England Journal of Medicine

Volumn 353, Issue 11, 2005, Pages 1159-1161

  Boden, William E ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATINE KINASE MB; ENOXAPARIN; TROPONIN; BIOLOGICAL MARKER; CREATINE KINASE; ISOENZYME;

ACUTE HEART INFARCTION; CARDIOVASCULAR RISK; EARLY DIAGNOSIS; EDITORIAL; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MEDICAL SOCIETY; MORTALITY; PATIENT MONITORING; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION; ANGIOCARDIOGRAPHY; BLOOD; CORONARY ARTERY BYPASS GRAFT; ELECTROCARDIOGRAPHY; HEART INFARCTION; NOTE; RECURRENT DISEASE; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CREATINE KINASE; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; HUMANS; ISOENZYMES; MYOCARDIAL INFARCTION; RECURRENCE; TIME FACTORS;

EID: 24944538001     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe058169     Document Type: Editorial

References (14)

1. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study. Lancet 1999;354:708-15.
2. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87.
3. Fox KA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial: Randomized Interventional Trial of Unstable Angina. Lancet 2002;360:743-51.
4. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2002;40:1366-74.
5. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent STsegment elevation. Eur Heart J 2002;23:1809-40. [Errata, Eur Heart J 2003;24:485, 1174-5.]
6. Mehta SR, Cannon CP, Fox KA, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005;293: 2908-17.
7. de Winter RJ, Windhausen F, Cornel JH, et al. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 2005;353:1095-104.
8. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959-69.
9. Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996;94:1528-36.
10. Tardiff BE, Califf RM, Tcheng JE, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol 1999;33:88-96.
11. Cantor WJ, Newby LK, Christenson RH, et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 2002;39:1738-44.
12. Roe MT, Mahaffey KW, Kilaru R, et al. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J 2004; 25:313-21.
13. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-504.
14. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.